End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.085 EUR | -5.66% | -44.42% | -51.49% |
May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 28.79M 31.32M | Sales 2022 | 25.74M 28M | Capitalization | 97.31M 106M |
---|---|---|---|---|---|
Net income 2021 | 38M 41.35M | Net income 2022 | -44M -47.87M | EV / Sales 2021 | 2.79 x |
Net cash position 2021 | 3.61M 3.93M | Net cash position 2022 | 4.88M 5.3M | EV / Sales 2022 | 3.59 x |
P/E ratio 2021 |
2.18
x | P/E ratio 2022 |
-1.98
x | Employees | 92 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 32.4% |
Latest transcript on Biofrontera AG
1 day | -5.66% | ||
1 week | -44.42% | ||
Current month | -44.42% | ||
1 month | -42.79% | ||
3 months | -56.09% | ||
6 months | -61.56% | ||
Current year | -51.49% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 46 | 21-12-13 |
Helge Lubenow
CHM | Chairman | 56 | 21-12-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 4.085 | -5.66% | 2,706 |
24-05-14 | 4.33 | -36.36% | 1,878 |
24-05-13 | 6.804 | -5.26% | 2,180 |
24-05-10 | 7.182 | -2.84% | 599 |
24-05-09 | 7.392 | +0.57% | 95 |
End-of-day quote Xetra, May 14, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.49% | 13.49M | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- B8FK Stock